Wang Hai-Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wang Hai-Chang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Cao Yan-Jie
From the *Department of Cardiology, Xijing Hospital; †Department of Anesthesiology, Xijing Hospital; ‡Department of Statistics; and §Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, PR China
1 shared publicationDong Hui
From the *Department of Cardiology, Xijing Hospital; †Department of Anesthesiology, Xijing Hospital; ‡Department of Statistics; and §Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, PR China
1 shared publicationFan Yan-Hong
Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Xi'an, PR China
1 shared publicationPan Mm Qing
From the *Department of Cardiology, Xijing Hospital; †Department of Anesthesiology, Xijing Hospital; ‡Department of Statistics; and §Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, PR China
1 shared publicationShang Lei
From the *Department of Cardiology, Xijing Hospital; †Department of Anesthesiology, Xijing Hospital; ‡Department of Statistics; and §Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, PR China
1 shared publicationZhang Wei
From the *Department of Cardiology, Xijing Hospital; †Department of Anesthesiology, Xijing Hospital; ‡Department of Statistics; and §Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, PR China
1 shared publication
Latest Publications
- 1 May 2010
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 55 (5) , 489-495
Effects of Arginine Vasopressin on Differentiation of Cardiac Fibroblasts Into Myofibroblasts
Background: Differentiation of cardiac fibroblasts (CFs) into myofibroblasts is a critical event in the initiation of myocardial fibrosis (MF). Previous studies have shown that arginine vasopressin (AVP) facilitates MF. However, the effects of AVP on CFs-myofibroblasts transformation, and its possible mechanisms are still unknown. Methods: CFs obtained from neonatal Sprague-Dawley rats were stimulated with AVP in the absence or presence of AVP V1a receptor specific antagonist [d(CH2)5Tyr2(Me)]AVP. CFs-myofibroblast transformation was detected by expression of α-smooth muscle actin (α-SMA) and collagen synthesis. Western bolt and immunofluorescent staining were used to detect expression of α-SMA, [3H]Proline incorporation was used to detect collagen synthesis. AVP-induced transforming growth factor-β1 (TGF-β1) secretion was detected by enzyme-linked immunosorbent assay. CFs was also stimulated with exogenous TGF-β1 to find out the required dose to induce CFs-myofibroblast transformation. Results: 10−6 mol/L AVP increased α-SMA expression and collagen synthesis significantly, and this effect was blocked by [d(CH2)5Tyr2(Me)]AVP at the concentration of 10−7 mol/L. Meanwhile, AVP significantly increased TGF-β1 secretion of CFs in a dose-dependent manner, and this effect was also blocked by 10−7 mol/L [d(CH2)5Tyr2(Me)]AVP. However, the maximum production of biologic active TGF-β1 induced by AVP is far less than the dose of exogenous TGF-β1 needed to induce CFs-myofibroblast transformation. Conclusions: AVP can induce CFs-myofibroblast transformation via its V1a receptor, AVP-induced increase of TGF-β1 synthesis, which also is mediated by V1a receptor, may play a minor role in the transformation. Inducing differentiation of CFs into myofibroblasts may be a mechanism of AVP contributing to MF.
- 1 May 2010
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 55 (5) , 489-495
Effects of Arginine Vasopressin on Differentiation of Cardiac Fibroblasts Into Myofibroblasts
Background: Differentiation of cardiac fibroblasts (CFs) into myofibroblasts is a critical event in the initiation of myocardial fibrosis (MF). Previous studies have shown that arginine vasopressin (AVP) facilitates MF. However, the effects of AVP on CFs-myofibroblasts transformation, and its possible mechanisms are still unknown. Methods: CFs obtained from neonatal Sprague-Dawley rats were stimulated with AVP in the absence or presence of AVP V1a receptor specific antagonist [d(CH2)5Tyr2(Me)]AVP. CFs-myofibroblast transformation was detected by expression of α-smooth muscle actin (α-SMA) and collagen synthesis. Western bolt and immunofluorescent staining were used to detect expression of α-SMA, [3H]Proline incorporation was used to detect collagen synthesis. AVP-induced transforming growth factor-β1 (TGF-β1) secretion was detected by enzyme-linked immunosorbent assay. CFs was also stimulated with exogenous TGF-β1 to find out the required dose to induce CFs-myofibroblast transformation. Results: 10−6 mol/L AVP increased α-SMA expression and collagen synthesis significantly, and this effect was blocked by [d(CH2)5Tyr2(Me)]AVP at the concentration of 10−7 mol/L. Meanwhile, AVP significantly increased TGF-β1 secretion of CFs in a dose-dependent manner, and this effect was also blocked by 10−7 mol/L [d(CH2)5Tyr2(Me)]AVP. However, the maximum production of biologic active TGF-β1 induced by AVP is far less than the dose of exogenous TGF-β1 needed to induce CFs-myofibroblast transformation. Conclusions: AVP can induce CFs-myofibroblast transformation via its V1a receptor, AVP-induced increase of TGF-β1 synthesis, which also is mediated by V1a receptor, may play a minor role in the transformation. Inducing differentiation of CFs into myofibroblasts may be a mechanism of AVP contributing to MF.